Paragard T 380a
Payments companies reported to CMS as associated with Paragard T 380a. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Paragard T 380a, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Paragard T 380a
These are the largest totals companies reported as associated with Paragard T 380a. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Laura Mckain | Wilmington, NC | Obstetrics & Gynecology | $39,081.25 |
| Karen Tang | Bryn Mawr, PA | Gynecology | $30,000.00 |
| Christine Sterling | Los Angeles, CA | Obstetrics & Gynecology | $29,500.00 |
| Elizabeth Rodgers | New York, NY | Obstetrics & Gynecology | $13,088.91 |
| Aileen Gariepy | New York, NY | Obstetrics & Gynecology | $2,330.00 |
| Neil Simmerman | Detroit, MI | Obstetrics & Gynecology | $2,280.00 |
| Lisa Bayer | Portland, OR | Obstetrics & Gynecology | $2,180.00 |
| Shawana Moore | Philadelphia, PA | Women'S Health (Nurse Practitioner) | $1,554.73 |
| Lonna Gordon | Orlando, FL | Adolescent Medicine (Pediatrics) | $1,530.00 |
| Taylore Passero | Depew, NY | Medical | $1,494.72 |
Prescribed Paragard T 380a?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.